Mineralys Therapeutics (MLYS) Proxy filing summary

Voting matters and shareholder proposals

• Election of three Class III directors for a three-year term expiring at the 2029 annual meeting, with nominees Srinivas Akkaraju, Brian Taylor Slingsby, and Daphne Karydas recommended for election.

• Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Proxies are authorized to vote on any other business that may properly come before the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and the auditor ratification.

Audit committee and external auditor matters

• Ernst & Young LLP proposed for ratification as independent auditor for the 2026 fiscal year.